108 related articles for article (PubMed ID: 30312728)
1. Natural compound Tetrocarcin-A downregulates Junctional Adhesion Molecule-A in conjunction with HER2 and inhibitor of apoptosis proteins and inhibits tumor cell growth.
Vellanki SH; Cruz RGB; Jahns H; Hudson L; Sette G; Eramo A; Hopkins AM
Cancer Lett; 2019 Jan; 440-441():23-34. PubMed ID: 30312728
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic Tetrocarcin-A Down-regulates JAM-A, IAPs and Induces Apoptosis in Triple-negative Breast Cancer Models.
Vellanki SH; Cruz RGB; Richards CE; Smith YE; Hudson L; Jahns H; Hopkins AM
Anticancer Res; 2019 Mar; 39(3):1197-1204. PubMed ID: 30842150
[TBL] [Abstract][Full Text] [Related]
3. Cleavage of the extracellular domain of junctional adhesion molecule-A is associated with resistance to anti-HER2 therapies in breast cancer settings.
Leech AO; Vellanki SH; Rutherford EJ; Keogh A; Jahns H; Hudson L; O'Donovan N; Sabri S; Abdulkarim B; Sheehan KM; Kay EW; Young LS; Hill ADK; Smith YE; Hopkins AM
Breast Cancer Res; 2018 Nov; 20(1):140. PubMed ID: 30458861
[TBL] [Abstract][Full Text] [Related]
4. Junctional adhesion molecule-A is co-expressed with HER2 in breast tumors and acts as a novel regulator of HER2 protein degradation and signaling.
Brennan K; McSherry EA; Hudson L; Kay EW; Hill AD; Young LS; Hopkins AM
Oncogene; 2013 May; 32(22):2799-804. PubMed ID: 22751120
[TBL] [Abstract][Full Text] [Related]
5. PTK6 inhibition promotes apoptosis of Lapatinib-resistant Her2(+) breast cancer cells by inducing Bim.
Park SH; Ito K; Olcott W; Katsyv I; Halstead-Nussloch G; Irie HY
Breast Cancer Res; 2015 Jun; 17(1):86. PubMed ID: 26084280
[TBL] [Abstract][Full Text] [Related]
6. A Transcriptional Link between HER2, JAM-A and FOXA1 in Breast Cancer.
Cruz RGB; Madden SF; Brennan K; Hopkins AM
Cells; 2022 Feb; 11(4):. PubMed ID: 35203384
[TBL] [Abstract][Full Text] [Related]
7. Disulfiram targets cancer stem-like properties and the HER2/Akt signaling pathway in HER2-positive breast cancer.
Kim JY; Cho Y; Oh E; Lee N; An H; Sung D; Cho TM; Seo JH
Cancer Lett; 2016 Aug; 379(1):39-48. PubMed ID: 27238567
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-β1 attenuates junctional adhesion molecule-A and contributes to breast cancer cell invasion.
Wang Y; Lui WY
Eur J Cancer; 2012 Dec; 48(18):3475-87. PubMed ID: 22647687
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis and inactivation of the PI3-kinase pathway by tetrocarcin A in breast cancers.
Nakajima H; Sakaguchi K; Fujiwara I; Mizuta M; Tsuruga M; Magae J; Mizuta N
Biochem Biophys Res Commun; 2007 Apr; 356(1):260-5. PubMed ID: 17350598
[TBL] [Abstract][Full Text] [Related]
10. The potential utility of acetyltanshinone IIA in the treatment of HER2-overexpressed breast cancer: Induction of cancer cell death by targeting apoptotic and metabolic signaling pathways.
Guerram M; Jiang ZZ; Yousef BA; Hamdi AM; Hassan HM; Yuan ZQ; Luo HW; Zhu X; Zhang LY
Oncotarget; 2015 Sep; 6(26):21865-77. PubMed ID: 26068969
[TBL] [Abstract][Full Text] [Related]
11. JAM-A overexpression is related to disease progression in diffuse large B-cell lymphoma and downregulated by lenalidomide.
Xu PP; Sun YF; Fang Y; Song Q; Yan ZX; Chen Y; Jiang XF; Fei XC; Zhao Y; Leboeuf C; Li B; Wang CF; Janin A; Wang L; Zhao WL
Sci Rep; 2017 Aug; 7(1):7433. PubMed ID: 28785100
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer cell migration is regulated through junctional adhesion molecule-A-mediated activation of Rap1 GTPase.
McSherry EA; Brennan K; Hudson L; Hill AD; Hopkins AM
Breast Cancer Res; 2011 Mar; 13(2):R31. PubMed ID: 21429211
[TBL] [Abstract][Full Text] [Related]
13. Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells.
Asanuma H; Torigoe T; Kamiguchi K; Hirohashi Y; Ohmura T; Hirata K; Sato M; Sato N
Cancer Res; 2005 Dec; 65(23):11018-25. PubMed ID: 16322251
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of junctional adhesion molecule-A is a contributing factor for breast cancer cell invasion.
Naik MU; Naik TU; Suckow AT; Duncan MK; Naik UP
Cancer Res; 2008 Apr; 68(7):2194-203. PubMed ID: 18381425
[TBL] [Abstract][Full Text] [Related]
15. Junctional adhesion molecule-A promotes proliferation and inhibits apoptosis of gastric cancer.
Ikeo K; Oshima T; Shan J; Matsui H; Tomita T; Fukui H; Watari J; Miwa H
Hepatogastroenterology; 2015; 62(138):540-5. PubMed ID: 25916097
[TBL] [Abstract][Full Text] [Related]
16. miR-145-dependent targeting of junctional adhesion molecule A and modulation of fascin expression are associated with reduced breast cancer cell motility and invasiveness.
Götte M; Mohr C; Koo CY; Stock C; Vaske AK; Viola M; Ibrahim SA; Peddibhotla S; Teng YH; Low JY; Ebnet K; Kiesel L; Yip GW
Oncogene; 2010 Dec; 29(50):6569-80. PubMed ID: 20818426
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation of junctional adhesion molecule-A via p63/GATA-3 in head and neck squamous cell carcinoma.
Kakuki T; Kurose M; Takano K; Kondoh A; Obata K; Nomura K; Miyata R; Kaneko Y; Konno T; Takahashi S; Hatakeyama T; Kohno T; Himi T; Kojima T
Oncotarget; 2016 Jun; 7(23):33887-900. PubMed ID: 27036044
[TBL] [Abstract][Full Text] [Related]
18. Low junctional adhesion molecule A expression correlates with poor prognosis in gastric cancer.
Huang JY; Xu YY; Sun Z; Wang ZN; Zhu Z; Song YX; Luo Y; Zhang X; Xu HM
J Surg Res; 2014 Dec; 192(2):494-502. PubMed ID: 25033702
[TBL] [Abstract][Full Text] [Related]
19. Novel Hsp90 inhibitor FW-04-806 displays potent antitumor effects in HER2-positive breast cancer cells as a single agent or in combination with lapatinib.
Huang W; Wu QD; Zhang M; Kong YL; Cao PR; Zheng W; Xu JH; Ye M
Cancer Lett; 2015 Jan; 356(2 Pt B):862-71. PubMed ID: 25449780
[TBL] [Abstract][Full Text] [Related]
20. Human Epidermal Growth Factor Receptor-3 Expression Is Regulated at Transcriptional Level in Breast Cancer Settings by Junctional Adhesion Molecule-A via a Pathway Involving Beta-Catenin and FOXA1.
Cruz RGB; Madden SF; Richards CE; Vellanki SH; Jahns H; Hudson L; Fay J; O'Farrell N; Sheehan K; Jirström K; Brennan K; Hopkins AM
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33669586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]